Saperconazole is a broad-spectrum antifungal agent. It acts by selective inhibiting the cytochrome P-450-dependent ergosterol synthesis in Candida albicans, Aspergillus fumigatus and Trichophyton mentagrophytes, with in vitro and in vivo activity against F. pedrosoi. References: Meerpoel L, Heeres J, Backx LJ, Van der Veken LJ, Hendrickx R, Corens D, De Groot A, Leurs S, Van der Eycken L, Weerts J, Luyts P, Van Gerven F, Woestenborghs FA, Van Breda A, Oris M, van Dorsselaer P, Willemsens GH, Bellens D, Marichal PJ, Vanden Bossche HF, Odds FC. Synthesis and in vitro and in vivo antifungal activity of the hydroxy metabolites of saperconazole. ChemMedChem. 2010 May 3;5(5):757-69. doi: 10.1002/cmdc.201000040. PubMed PMID: 20379992.

纯度：≥98%

CAS：110588-57-3